共 102 条
[1]
Schweitzer J(2015)Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial Ann Hematol 94 1327-1336
[2]
Zimmermann M(2015)Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study Blood 126 1575-1584
[3]
Rasche M(2019)Outcome of childhood acute megakaryoblastic leukemia: children’s cancer hospital Egypt 57357 experience Clin Lymphoma Myeloma Leuk 19 e142-e152
[4]
von Neuhoff C(2018)The comparative sensitivity of immunohistochemical markers of megakaryocytic differentiation in acute megakaryoblastic leukemia Am J Clin Pathol 150 461-467
[5]
Creutzig U(2020)A retrospective study of myeloid leukaemia in children with Down syndrome in Ireland Ir J Med Sci 189 979-984
[6]
Dworzak M(2019)Molecular features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia Expert Rev Hematol 12 285-293
[7]
Inaba H(2017)Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol Br J Haematol 177 116-126
[8]
Zhou Y(2017)Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial Pediatr Hematol Oncol 34 425-427
[9]
Abla O(2016)Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study Blood 127 3424-3430
[10]
Adachi S(2012)Lineage switch in childhood acute leukemia: an unusual event with poor outcome Am J Hematol 87 890-897